| 1 | welcome labonovum blok system | | | | | | | 1 | 0.56% |
| 2 | the lab 3 analytical | | | | | | | 1 | 0.56% |
| 3 | sercol® manufacturing 2 automation | | | | | | | 1 | 0.56% |
| 4 | manufacturing 2 automation of | | | | | | | 1 | 0.56% |
| 5 | 2 automation of sercol® | | | | | | | 1 | 0.56% |
| 6 | automation of sercol® serum | | | | | | | 1 | 0.56% |
| 7 | processing at the lab | | | | | | | 1 | 0.56% |
| 8 | at the lab 3 | | | | | | | 1 | 0.56% |
| 9 | lab 3 analytical and | | | | | | | 1 | 0.56% |
| 10 | upscaling of sercol® manufacturing | | | | | | | 1 | 0.56% |
| 11 | 3 analytical and clinical | | | | | | | 1 | 0.56% |
| 12 | analytical and clinical validation | | | | | | | 1 | 0.56% |
| 13 | and clinical validation of | | | | | | | 1 | 0.56% |
| 14 | clinical validation of the | | | | | | | 1 | 0.56% |
| 15 | sercol® device and automated | | | | | | | 1 | 0.56% |
| 16 | device and automated serum | | | | | | | 1 | 0.56% |
| 17 | of sercol® manufacturing 2 | | | | | | | 1 | 0.56% |
| 18 | 1 upscaling of sercol® | | | | | | | 1 | 0.56% |
| 19 | automated serum processing 4 | | | | | | | 1 | 0.56% |
| 20 | of the scaut project | | | | | | | 1 | 0.56% |
| 21 | a reliable and easy | | | | | | | 1 | 0.56% |
| 22 | reliable and easy to | | | | | | | 1 | 0.56% |
| 23 | and easy to use | | | | | | | 1 | 0.56% |
| 24 | easy to use device | | | | | | | 1 | 0.56% |
| 25 | to use device the | | | | | | | 1 | 0.56% |
| 26 | use device the aim | | | | | | | 1 | 0.56% |
| 27 | the scaut project is | | | | | | | 1 | 0.56% |
| 28 | launch of sercol® by | | | | | | | 1 | 0.56% |
| 29 | scaut project is to | | | | | | | 1 | 0.56% |
| 30 | labonovum blok system supply | | | | | | | 1 | 0.56% |
| 31 | is to accelerate the | | | | | | | 1 | 0.56% |
| 32 | to accelerate the market | | | | | | | 1 | 0.56% |
| 33 | accelerate the market launch | | | | | | | 1 | 0.56% |
| 34 | the market launch of | | | | | | | 1 | 0.56% |
| 35 | market launch of sercol® | | | | | | | 1 | 0.56% |
| 36 | and automated serum processing | | | | | | | 1 | 0.56% |
| 37 | serum processing 4 obtaining | | | | | | | 1 | 0.56% |
| 38 | centrifuge with a reliable | | | | | | | 1 | 0.56% |
| 39 | system supply bv rooswijkweg | | | | | | | 1 | 0.56% |
| 40 | and innovation programme under | | | | | | | 1 | 0.56% |